Advertisement

NO Activity and Rho Kinase Activity

  • Michael Gralinski
  • Liomar A. A. Neves
  • Olga Tiniakova
Living reference work entry

Abstract

The endothelium releases a labile, diffusible, vasorelaxing substance that has been termed endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadzki 1980). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor (Palmer et al. 1987; Vanhoutte 1999).

Keywords

Nitric Oxide Nitric Oxide Nitric Oxide Release Nitric Oxide Formation Canine Coronary Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

General Considerations on Nitric Oxide

  1. Andreadis AA, Hazen SL, Comhair SAA, Erzurum SC (2003) Oxidative and nitrosative events in asthma. Free Radical Biol Med 15:213–225Google Scholar
  2. Davis KL, Martin E, Turko IV, Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203–236PubMedGoogle Scholar
  3. Feihl F, Waeber B, Liaudet L (2001) Is nitric overproduction the target of choice for management of septic shock? Pharmacol Ther 91:179–213PubMedGoogle Scholar
  4. Fiorucci S, Antonelli E, Burgaud JL, Morelli A (2002) Nitric oxide-releasing NSAIDs. Drug Saf 24:801–811Google Scholar
  5. Förstermann U, Kleinert H (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg’s Arch Pharmacol 352:351–364Google Scholar
  6. Förstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Murad F (1992) Characterization and classification of constitutive and inducible isoforms of nitric oxide synthase in various cell types. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 21–23Google Scholar
  7. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376Google Scholar
  8. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion. The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105:1497–1502PubMedGoogle Scholar
  9. Halliwell B (1997) What nitrates tyrosine? Is nitrotyrosine specific as biomarker of peroxynitrite? FEBS Lett 411:157–160PubMedGoogle Scholar
  10. Hickey MJ (2001) Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci 100:1–11PubMedGoogle Scholar
  11. Hropot M, Langer KH, Wiemer G, Grötsch H, Linz W (2003) Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Naunyn-Schmiedebergs Arch Pharmacol 367:312–317PubMedGoogle Scholar
  12. Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey MM, Wilcox JN, Harrison DG, Levy JH (1999) Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation 99:53–59PubMedGoogle Scholar
  13. Kajekar R, Moore PK, Brain SD (1995) Essential role for nitric oxide in neurogenic inflammation in rats cutaneous microcirculation. Evidence for endothelium-independent mechanism. Circ Res 76:441–447PubMedGoogle Scholar
  14. Lamontagne D, Pohl U, Busse R (1991) N G-Nitro-l-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart. Pflüger’s Arch 418:266–270Google Scholar
  15. McIntyre M, Bohr DF, Dominiczak AF (1999) Endothelial function in hypertension. The role of superoxide anion. Hypertension 34:539–545PubMedGoogle Scholar
  16. Megson IL (2000) Nitric oxide donor drugs. Drugs Future 25:701–715Google Scholar
  17. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142Google Scholar
  18. Moore PK, al-Swayeh OA, Chong NWS, Evans RA, Gibson A (1990) L-NG-nitro arginine (L-NOARG), a novel, l-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99:408–412PubMedCentralPubMedGoogle Scholar
  19. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526PubMedGoogle Scholar
  20. Pieper AA, Verma A, Zhang J, Snyder SH (1999) Poly(ADPribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171–181PubMedGoogle Scholar
  21. Rand MJ, Li CG (1995) Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission. Ann Rev Phys 57:659–682Google Scholar
  22. Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 86:3375–3378PubMedCentralPubMedGoogle Scholar
  23. RiberoMO AE, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303Google Scholar
  24. Schrör K, Förster S, Woditsch I, Schröder H (1989) Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessel tissue. J Cardiovasc Pharmacol 14(Suppl 11):S29–S34PubMedGoogle Scholar
  25. Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:L402–L413Google Scholar
  26. Southam E, Garthwaite J (1993) The nitric oxide-cyclic GMP signalling pathway in the rat brain. Neuropharmacology 32:1267–1277PubMedGoogle Scholar
  27. Susswein AJ, Katzoff A, Miller N, Hurwitz I (2004) Nitric oxide and memory. Neuroscientist 10:153–162PubMedGoogle Scholar
  28. Szabó C (1996) DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 21:855–869PubMedGoogle Scholar
  29. Szabó C, Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100:723–735PubMedCentralPubMedGoogle Scholar
  30. Umans JG, Levi R (1995) Nitric oxide in the regulation of blood flow and arterial pressure. Ann Rev Phys 57:771–790Google Scholar
  31. Vanhoutte PM (1999) How to assess endothelial function in human blood vessels. J Hypertens 17:1047–1058PubMedGoogle Scholar
  32. Willmot M, Gray L, Gibson C, Murphy S, Bath PMW (2005) A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12:141–149PubMedGoogle Scholar
  33. Zanzinger J (1999) Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 43:639–649PubMedGoogle Scholar

Bioassay of EDRF Release

  1. Riezebos J, Beems RB, Vleeming W, van Amsterdam JGC, Meijer GW, de Wildt DJ, Porsius AJ, Wemer J (1994) Comparison of Israpidine and Ramipril in cholesterol-fed rabbits: effect on progression of atherosclerosis and endothelial dysfunction. J Cardiovasc Pharmacol 23:415–423PubMedGoogle Scholar
  2. Winn MJ, Panus PC, Norton P, Dai J (1992) Computer system for the acquisition and analysis of vascular contractility. Application to a bioassay of endothelial cell function. J Pharmacol Toxicol Methods 28:49–55PubMedGoogle Scholar

Isolated Arteries with and Without Endothelium

  1. Bohn H, Schönafinger K (1989) Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 14(Suppl 11):S6–S12PubMedGoogle Scholar
  2. Chu A, Cobb FR (1987) Vasoactive effects of serotonin on proximal coronary arteries in awake dogs. Circ Res 61(Suppl II):II81–II87PubMedGoogle Scholar
  3. Desta B, Nakashima M, Kirchengast M, Vanhoutte PM, Boulanger CM (1995) Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor Trandolaprilat in isolated canine coronary arteries. J Pharmacol Exp Ther 272:885–891PubMedGoogle Scholar
  4. Fujimoto M, Mihara S, Nakajima S, Ueda M, Nakamura M, Sakurai K (1992) A novel, non-peptide endothelin antagonist, isolated from bayberry, Myrica cerifera. FEBS Lett 305:41–44PubMedGoogle Scholar
  5. Fukuroda T, Nishikibe M, Ohta Y, Ihara M, Yano M, Ishikawa K, Fukami T, Ikemoto F (1992) Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153. Life Sci 50:PL-107–PL-112Google Scholar
  6. Furchgott RF (1993) The discovery of endothelium-dependent relaxation. Circulation 87(Suppl V):V3–V8Google Scholar
  7. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376Google Scholar
  8. Hayashi Y, Tomoike H, Nagasawa K, Yamada A, Nishijima H, Adachi H, Nakamura M (1988) Functional and anatomical recovery of endothelium after denudation of coronary artery. Am J Physiol 254:H1081–H1090PubMedGoogle Scholar
  9. Jeremy JY, Dandona P (1989) Effect of endothelium removal on stimulatory and inhibitory modulation of rat aortic prostaglandin synthesis. Br J Pharmacol 96:243–250PubMedCentralPubMedGoogle Scholar
  10. Legan E, Sisson JA (1990) Method to denude rat aortic endothelium with saponin for phosphoinositide analysis in vascular smooth muscle. J Pharmacol Methods 23:31–39PubMedGoogle Scholar
  11. Linz W, Albus U, Wiemer G, Schölkens BA, König W (1986) Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. Klin Wschr 64(Suppl VI):27–30PubMedGoogle Scholar
  12. Peach MJ, Singer HA, Loeb AL (1985) Mechanism of endothelium-dependent vascular smooth muscle relaxation. Biochem Pharmacol 34:1867–1874PubMedGoogle Scholar
  13. Pelissier T, Miranda HF, Bustamante D, Paelle C, Pinardi G (1992) Removal of the endothelial layer in perfused mesenteric vascular bed of the rat. J Pharmacol Methods 27:41–44Google Scholar
  14. Pörsti I, Bara AT, Busse R, Hecker M (1994) Release of nitric oxide by angiotensin-(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 111:652–654PubMedCentralPubMedGoogle Scholar
  15. Ren LM, Nakane T, Chiba S (1993) Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J Cardiovasc Pharmacol 22:841–846PubMedGoogle Scholar
  16. Reynolds EE, Mok LLS (1990) Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin. J Pharmacol Exp Ther 252:915–921PubMedGoogle Scholar
  17. Scivoletto R, Carvalho MHC (1984) Cardionatrin causes vasodilation in vitro which is not dependent on the presence of endothelial cells. Eur J Pharmacol 101:143–145PubMedGoogle Scholar
  18. Terrón JA (1996) GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery. Eur J Pharmacol 300:109–112PubMedGoogle Scholar
  19. Tracey WR, Linden J, Peach MJ, Johns RA (1990) Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF. J Pharmacol Exp Ther 252:922–928PubMedGoogle Scholar
  20. Wiemer G, Becker RHA, Jablonka B, Rosenkranz G, Schölkens BA, Linz W (1992) Effects of converting enzyme inhibitors and the calcium antagonist nifedipine alone and in combination on precontracted isolated rabbit aortic rings. Arzneim Forsch/Drug Res 42:795–797Google Scholar

Nitric Oxide Formation by Cultured Endothelial Cells

  1. Böger RH, Bode-Böger SM (2001) The clinical pharmacology of l-arginine. Annu Rev Pharmacol Toxicol 41:79–99PubMedGoogle Scholar
  2. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE (1992) Bradykinin stimulates l-arginine transport and nitric oxide release in vascular endothelial cells. formation in cytokinetreated rat hepatocytes and in blood and liver during sepsis. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 80–84Google Scholar
  3. Busse R, Lamontagne D (1991) Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn-Schmiedeberg’s Arch Pharmacol 344:126–129Google Scholar
  4. Feelisch M, Noack E (1987) Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol 142:465–469PubMedGoogle Scholar
  5. Gabriel C, Camins A, Sureda FX, Aquirre L, Escubedo E, Pallàs M, Camarasa J (1997) Determination of nitric oxide generation in mammalian neurons using dichlorofluorescin diacetate and flow cytometry. J Pharmacol Toxicol Meth 38:93–98Google Scholar
  6. Gerzer R, Hofmann F, Schultz G (1981) Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem 116:479–486PubMedGoogle Scholar
  7. Griffiths MJD, Messent M, McAllister RJ, Evans TW (1993) Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110:963–968PubMedCentralPubMedGoogle Scholar
  8. Heath R, Brynat B, Horton JK (1992) Which cyclic GMP assay? In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 98–102Google Scholar
  9. Hecker M, Boese M, Schini-Kerth VB, Mülsch A, Busse R (1995) Characterization of the stable l-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an N G-hydroxy-l-arginine-nitric oxide adduct. Proc Natl Acad Sci U S A 92:4671–4675PubMedCentralPubMedGoogle Scholar
  10. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J, Schölkens BA (1991) Hoe 140 a new potent and long acting bradykinin antagonist: in vitro studies. Br J Pharmacol 102:769–773PubMedCentralPubMedGoogle Scholar
  11. Holzmann S, Kukovetz WR, Windischhofer W, Paschke E, Graier WF (1994) Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-l-arginine in coronary arteries. J Cardiovasc Pharmacol 23:747–756PubMedGoogle Scholar
  12. Ichimori K, Pronai L, Fukahori M, Arroyo CM, Nakzawa H (1992) Spin trapping/electron paramagnetic spectroscopy analysis of endothelium-derived relaxing factors and their intermediates in human platelets. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 68–69Google Scholar
  13. Ishida Y, Hashimoto M, Fukushima S, Masumura S, Sasaki T, Nakayama K, Tamura K, Murakami E, Isokawa S, Momose K (1996) A nitric oxide-sensitive electrode: requirement of lower oxygen concentration for detecting nitric oxide from the tissue. J Pharmacol Toxicol Meth 35:19–24Google Scholar
  14. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745–2756PubMedCentralPubMedGoogle Scholar
  15. Lancester JR Jr, Stadler J, Billiar TR, Bergonia HA, Kim YM, Piette LH, Simmons RL (1992) Electron-paramagnetic resonance detection of iron-nitrosyl formation in cytokine-treated rat hepatocytes and in blood and liver during sepsis. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 76–80Google Scholar
  16. Linz W, Wiemer G, Schölkens BA (1992) ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol 24:909–919PubMedGoogle Scholar
  17. Linz W, Wohlfart P, Schoelkens BA, Becker RHA, Malinski T, Wiemer G (1999) Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 34:291–295Google Scholar
  18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  19. Lückhoff A, Pohl U, Mülsch A, Busse R (1988) Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol 95:189–196PubMedCentralPubMedGoogle Scholar
  20. Malinski T, Taha Z (1992) Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676–678PubMedGoogle Scholar
  21. Malinski T, Huk I (2001) Measurement of nitric oxide in single cells and tissue using a porphyrinic microsensor. Curr Protoc Neurosci Chapter 7:Unit7.14Google Scholar
  22. Malinski T (2015) Using nanosensors for in situ monitoring and measurement of nitric oxide and peroxynitrite in a single cell. Methods Mol Biol 1208:139–155PubMedGoogle Scholar
  23. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142Google Scholar
  24. Mordvintcev P, Mülsch A, Busse R, Vanin A (1991) On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem 19:142–146Google Scholar
  25. Mülsch A, Böhme E, Busse R (1987) Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol 135:247–250PubMedGoogle Scholar
  26. Nakazawa H, Fukahori M, Murata T, Furuya T (1992) Online monitoring of nitric oxide generation from isolated perfused rat lung using decrease in superoxide-dependent chemiluminescence. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, p 69Google Scholar
  27. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051–3064PubMedGoogle Scholar
  28. Rosales OR, Isales CM, Barrett PQ, Brophy C, Sumpio BE (1997) Exposure of endothelial cells to cyclic strain induces elevations of cytosolic Ca2+ concentration through mobilization of intracellular and extracellular pools. Biochem J 326:385–392PubMedCentralPubMedGoogle Scholar
  29. Shephard JT, Vanhoutte PM (1991) Endothelium-derived relaxing (EDRF) and contracting factors (EDCF) in the control of cardiovascular homeostasis: the pioneering observations. In: Rubanyi GM (ed) Cardiovascular significance of Endothelium-Derived vasoactive factors. Futura Publ Comp, Mount Kisco, pp 39–64Google Scholar
  30. Shibuki K (1990) An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neurosci Res 9:69–76PubMedGoogle Scholar
  31. Smits GJM, Lefebvre RA (1997) Evaluation of an electrochemical microprobe for direct NO measurement in the rat gastric fundus. J Pharmacol Toxicol Meth 37:97–103Google Scholar
  32. Steel-Goodwin L, Arroyo CM, Gray B, Carmichael AJ (1992) Electron paramagnetic resonance detection of nitric oxide-dependent spin adducts in mouse jejunum. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 80–84Google Scholar
  33. Sumpio BE, Banes AJ, Levin LG, Johnson G Jr (1987) Mechanical stress stimulates aortic endothelial cells to proliferate. J Vasc Surg 6:252–256PubMedGoogle Scholar
  34. Wiemer G, Schölkens BA, Becker RHA, Busse R (1991) Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium derived bradykinin. Hypertension 18:558–563PubMedGoogle Scholar
  35. Wiemer G, Popp R, Schölkens BA, Gögelein H (1994) Enhancement of cytosolic calcium, prostaglandin and nitric oxide by bradykinin and the ACE inhibitor ramiprilate in porcine brain capillary endothelial cells. Brain Res 638:261–266PubMedGoogle Scholar

Expression of Nitric Oxide Synthase

  1. Baynosa RC, Naig AL, Murphy PS, Fang XH, Stephenson LL, Khiabani KT, Wang WZ, Zamboni WA (2013) The effect of hyperbaric oxygen on nitric oxide synthase activity and expression in ischemia-reperfusion injury. J Surg Res 183(1):355–361PubMedGoogle Scholar
  2. Bauersachs J, Bouloumié A, Fraccarollo D, Hu K, Busse R, Ertl G (1998) Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension. Eur J Pharmacol 362:77–81PubMedGoogle Scholar
  3. Bauersachs J, Bouloumié A, Fraccarollo D, Hu K, Busse R, Ertl G (1999) Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Role of enhanced vascular superoxide production. Circulation 100:292–298PubMedGoogle Scholar
  4. Chomczynski P, Sacchi N (1987) Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedGoogle Scholar
  5. Förstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Murad F (1992) Characterization and classification of constitutive and inducible isoforms of nitric oxide synthase in various cell types. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 21–23Google Scholar
  6. Förstermann U, Kleinert H (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg’s Arch Pharmacol 352:351–364Google Scholar
  7. Fukuto JM, Chaudhuri G (1995) Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 35:165–194PubMedGoogle Scholar
  8. Hevel JM, White KA, Marletta MA (1992) Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein and detection of enzyme-bound tetrahydrobiopterin. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 19–21Google Scholar
  9. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298:249–258PubMedCentralPubMedGoogle Scholar
  10. Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS, Moncada S (1992) Molecular oxygen is incorporated in nitric oxide and citrulline by constitutive and inducible nitric oxide synthases. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 7–14Google Scholar
  11. Linz W, Jessen T, Becker RHA, Schölkens BA, Wiemer G (1997) Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 96:3164–3172PubMedGoogle Scholar
  12. Linz W, Wohlfart P, Schoelkens BA, Becker RHA, Malinski T, Wiemer G (1999) Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 34:291–295Google Scholar
  13. Lund DD, Faraci FM, Miller FJ Jr, Heistad DD (2000) Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101:1027–1033PubMedGoogle Scholar
  14. Martins MA, Moss MB, Mendes IK, Aguila MB, Mandarim-de-Lacerda CA, Brunini TM, Mendes-Ribeiro AC (2014) Role of dietary fish oil on nitric oxide synthase activity and oxidative status in mice red blood cells. Food Funct 5(12):3208–3215PubMedGoogle Scholar
  15. Mayer B, John M, Heinzel B, Klatt P, Werner ER, Böhme E (1992) Properties of Ca2+-regulated brain nitric oxide synthase. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 4–6Google Scholar
  16. McCall TB, Feelisch M, Palmer RMJ, Moncada S (1991) Identification of N-iminoethyl-l-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol 102:234–238PubMedCentralPubMedGoogle Scholar
  17. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitroindazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 110:219–224PubMedCentralPubMedGoogle Scholar
  18. Moro MA, de Alba J, Leza JC, Lorenzo P, Fernández AP, Bentura ML, Boscá L, Lizasoain I (1998) Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 10:445–456PubMedGoogle Scholar
  19. Mungrue IN, Husain M, Stewart DJ (2002) The role of NOS in heart failure. Lessons from murine genetic models. Heart Fail Rev 7:407–422PubMedGoogle Scholar
  20. Mungrue IN, Bredt DS, Stewart DJ, Husain M (2003) From molecules to mammals: what’s NOS got to do with it ? Acta Physiol Scand 179:123–135PubMedGoogle Scholar
  21. Nakane M, Klinghöfer V, Kuk JE, Donnelly JL, Budzik GP, Pollock JS, Basha F, Carter GW (1995) Novel potent and selective inhibitors of inducible nitric oxide synthase. Mol Pharmacol 47:831–834PubMedGoogle Scholar
  22. Pollock JS, Mitchell JA, Warner TD, Schmidt HHHW, Nakana M, Förstermann U, Murad F (1992) Purification of nitric oxide synthases from endothelial cells. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 108–111Google Scholar
  23. Salter M, Knowles RG, Moncada S (1992) Widespread tissue distribution, species distribution and changes in activity of Ca2+-dependent and Ca2+-independent nitric oxide synthases. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 193–197Google Scholar
  24. Schmidt HHHW, Smith RM, Nakana M, Gagne GD, Miller MF, Pollock JS, Sheng H, Förstermann U, Murad F (1992) Type I nitric oxide synthase: purification, characterization and immunohistochemical localization. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. 2. Enzymology, biochemistry and immunology. Portland Press, London/Chapel Hill, pp 112–114Google Scholar
  25. Vargas HM, Cuevas JM, Ignarro LJ, Chaudhuri G (1991) Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-l-arginine on EDRF formation in the rat: evidence for continuous basal EDRF release. J Pharmacol Exp Ther 257:1208–1215PubMedGoogle Scholar
  26. Von der Leyen HE, Gibbbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ (1995) Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 92:1137–1141PubMedCentralPubMedGoogle Scholar

Inhibition of Rho Kinase

  1. Budzyn K, Marley PD, Sobey CG (2006) Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci 27:97–104PubMedGoogle Scholar
  2. Ishizaki T, Naito M, Fujisawa K, Maekawa M, Watanabe N, Saito Y, Narumiya S (1997) p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 404:118–124PubMedGoogle Scholar
  3. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S (2000) Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 57:976–983PubMedGoogle Scholar
  4. Ito K, Hirooka Y, Sakai K, Kishi T, Kaibuchi K, Shimokawa H, Takeshita A (2003) Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system. Possible involvement of neural mechanisms of hypertension. Circ Res 92:1337–13343PubMedGoogle Scholar
  5. Ito K, Hirooka Y, Kishi T, Kimura Y, Kaibuchi K, Shimokawa H, Takeshita A (2004) Rho/Rho-kinase pathway in the brain stem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 43:156–162PubMedGoogle Scholar
  6. Kobayashi N, Horinaka S, Mita SI, Nakano S, Honda T, Yoshida K, Kobayashi T, Matsuoka H (2002) Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts. Cardiovasc Res 55:757–767PubMedGoogle Scholar
  7. Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N, Kongo M, Kato S, Yamada N, Isaka N, Nakano T (2005) Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25:2088–2093PubMedGoogle Scholar
  8. Shimokawa H (2002) Rho-kinase as a novel therapeutic target in treatment of cardiovascular disease. J Cardiovasc Pharmacol 39:319–327PubMedGoogle Scholar
  9. Winaver J, Ovcharenko E, Rubinstein I, Gurbanov K, Pollesello P, Bishara B, Hoffman A, Abassi Z (2006) Involvement of Rho kinase pathway in the mechanisms of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol 290:H2007–H2014Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Michael Gralinski
    • 1
  • Liomar A. A. Neves
    • 1
  • Olga Tiniakova
    • 1
  1. 1.CorDynamics, Inc.ChicagoUSA

Personalised recommendations